Komori
Kawai Musical Instruments Manufacturing (7952) · FactUpdated to interim results

R&D expenses: ¥500 million

First written in FY2018-Q3. . Latest entry: FY2026-H1.

25entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – FY2026-H12018: 420182019: 420192020: 420202021: 320212022: 320222023: 320232024: 220242025: 22025
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 81 companies write about · 0 as a headwind · 20 as a tailwind

56 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 81 companies compared. The sentences above are computed from all 81.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Updated to interim resultsAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥252 million.」

    R&D expenses for the interim consolidated accounting period of FY2026 were disclosed as ¥252 million.
  2. FY2025Updated with full-year resultsAnnual report

    「The Company and its consolidated group had 86 R&D personnel, and R&D expenses were ¥473 million.」

    Updated to FY2025 full-year results showing 86 R&D personnel and ¥473 million in R&D expenses.
  3. FY2025-H1Updated to FY2025 interim resultsAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥252 million.」

    R&D expenses for the interim consolidated accounting period of FY2025 were disclosed as ¥252 million.
  4. FY2024-Q3Updated with cumulative third-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the third quarter were ¥312 million.」

    R&D expenses for the cumulative period of the third quarter of FY2024 were disclosed as ¥312 million.
  5. FY2024-Q2Updated with cumulative second-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the second quarter were ¥225 million.」

    R&D expenses for the cumulative period of the second quarter of FY2024 were disclosed as ¥225 million.
  6. FY2024-Q1Update to the following year's first-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the first quarter were ¥119 million.」

    R&D expenses for the cumulative period of the first quarter of FY2024 were disclosed as ¥119 million.
  7. FY2023-Q3Updated with cumulative third-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the third quarter were ¥367 million.」

    R&D expenses for the cumulative period of the third quarter were disclosed as ¥367 million.
  8. FY2023-Q2Updated with cumulative second-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the second quarter were ¥244 million.」

    R&D expenses for the cumulative period of the second quarter of FY2023 were disclosed as ¥244 million.
  9. FY2023-Q1Update to the following year's first-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the first quarter were ¥124 million.」

    R&D expenses for the cumulative period of the first quarter of FY2023 were disclosed as ¥124 million.
  10. FY2022-Q3Updated with cumulative third-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the third quarter were ¥380 million.」

    R&D expenses for the cumulative period of the third quarter of FY2022 were disclosed as ¥380 million.
  11. FY2022-Q2Updated with cumulative second-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the second quarter were ¥252 million.」

    R&D expenses for the cumulative period of the second quarter of FY2022 were disclosed as ¥252 million.
  12. FY2022-Q1Update to the following year's first-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the first quarter were ¥118 million.」

    R&D expenses for the cumulative period of the first quarter of FY2022 were disclosed as ¥118 million.
  13. FY2021-Q3Updated with cumulative third-quarter resultsAnnual report

    「Total R&D expenses for the current cumulative consolidated period of the third quarter were ¥364 million.」

    R&D expenses for the cumulative period of the third quarter of FY2021 were disclosed as ¥364 million.
  14. FY2021-Q2Updated with cumulative second-quarter resultsAnnual report

    「Total R&D expenses for the six-month period of the consolidated fiscal year were ¥236 million.」

    R&D expenses for the cumulative period of the second quarter of FY2021 were disclosed as ¥236 million.
  15. FY2021-Q1Update to the following year's first-quarter resultsAnnual report

    「Total R&D expenses for the three-month period of the consolidated fiscal year were ¥114 million.」

    The company disclosed R&D expenses of ¥114 million for the first quarter of FY2021.
  16. FY2020Updated with full-year resultsAnnual report

    「The number of R&D personnel at the company and across the consolidated group was 82, and R&D expenses were ¥639 million.」

    The company disclosed full-year results for the current fiscal year of 82 R&D personnel and R&D expenses of ¥639 million.
  17. FY2020-Q3Update to cumulative quarterly resultsAnnual report

    「Total R&D expenses for the nine-month period of the consolidated fiscal year were ¥533 million.」

    The company disclosed R&D expenses of ¥533 million for the nine-month period of the consolidated fiscal year.
  18. FY2020-Q2Update to cumulative quarterly resultsAnnual report

    「Total R&D expenses for the six-month period of the consolidated fiscal year were ¥341 million.」

    The company disclosed R&D expenses of ¥341 million for the six-month period of the consolidated fiscal year.
  19. FY2020-Q1Updated with quarterly resultsAnnual report

    「Total R&D expenses for the three-month period of the consolidated fiscal year were ¥172 million.」

    The company disclosed R&D expenses of ¥172 million for the three-month period of the consolidated fiscal year.
  20. FY2019Updated with full-year resultsAnnual report

    「The number of R&D personnel at the company and across the consolidated group was 81, and R&D expenses were 670 million yen.」

    The company disclosed full-year results of 81 R&D personnel and R&D expenses of ¥670 million.
  21. FY2019-Q3Update to cumulative quarterly resultsAnnual report

    「Total R&D expenses for the nine-month period of the consolidated fiscal year were ¥510 million.」

    The company disclosed R&D expenses of ¥510 million for the nine-month period of the consolidated fiscal year.
  22. FY2019-Q2Update to cumulative quarterly resultsAnnual report

    「Total R&D expenses for the six-month period of the consolidated fiscal year were ¥333 million.」

    The company disclosed R&D expenses of ¥333 million for the six-month period of the consolidated fiscal year.
  23. FY2019-Q1Updated with quarterly resultsAnnual report

    「Total R&D expenses for the three-month period of the consolidated fiscal year were ¥166 million.」

    In addition to the previous full-year R&D expenses of ¥648 million, the company disclosed R&D expenses of ¥166 million for the first-quarter cumulative period.
  24. FY2018Updated with full-year resultsAnnual report

    「The number of R&D personnel at the company and across the consolidated group was 80, and R&D expenses were ¥648 million.」

    The company disclosed full-year R&D expenses of ¥648 million and 80 R&D personnel, compared with R&D expenses of ¥500 million for the cumulative quarterly period.
  25. FY2018-Q3First statedAnnual report

    「Total R&D expenses for the nine-month period of the consolidated fiscal year were ¥500 million.」

    The company disclosed total R&D expenses of ¥500 million for the nine-month period of the consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kawai Musical Instruments Manufacturing's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.